The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the interesting thing between male and female the difference is the mice the female mice that were treated with IGF receptor antibody had a lot of of inflammatory markers right when we started there were 22 months and those inflammatory markers were really decreased with aging in males we had a little bit more inflammatory markers but they increased with the IGF treatment
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.